[EN] GLYCINE, MITOCHONDRIAL ONE-CARBON METABOLISM, AND CANCER<br/>[FR] GLYCINE, MÉTABOLISME MITOCHONDRIALE MONOCARBONÉ ET CANCER
申请人:GEN HOSPITAL CORP
公开号:WO2014150688A1
公开(公告)日:2014-09-25
Methods of treatment, diagnosis, and determining prognosis of subjects with cancer, generally comprising determining levels of glycine metabolism or a mitochondrial 1-carbon (1-C) pathway enzyme, e.g., SHMT2, MTHFD1L, or MTHFD2, and optionally administering an antifolate or an agent that inhibits a mitochondrial 1-carbon (1-C) pathway enzyme, e.g., SHMT2 or MTHFD2.